Two million HEK293T cells were seeded in a 100 mm cell culture petri-dish the day before transfection. Twelve ug of the plasmid (pCMV14-3X-Flag-SARS-CoV-2 S) was transfected with a 1:1 ratio of lipofectamine 2000 (Thermo Fisher scientific). After 48 h, the cells were gently washed with 1xdPBS and were harvested in FACS buffer (1xPBS + 10%FBS +1mM EDTA). Cells were washed in FACS buffer two to three times with gentle centrifugation (250 g) for 5 min at RT. Cells were resuspended in 3 ml of FACS buffer and the 0.1-0.2x106 cells were aliquoted in a 1.5 ml microcentrifuge as per the requirement. Each tube was incubated with 20 ug/ml of primary antibody (pooled mouse serum IgG from anti-RBD, anti-RBD+AddaVax, anti-RBD+imject, and control group was used as primary antibody) for 1 h at RT followed by washing with FACS buffer three times; here untransfected cells were also used as the untransfected mock control. Further cells were incubated with florescence dye conjugated secondary antibody (Alexa Fluor 488) at 1:400 dilution, followed by washing with FACS buffer and fixing with 4% PFA for 10 min at RT. Samples were acquired in BD FACSCanto II and raw data were analyzed using FlowJo software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.